| 000 | 01808 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513220046.0 | ||
| 264 | 0 | _c20000927 | |
| 008 | 200009s 0 0 eng d | ||
| 022 | _a0889-2229 | ||
| 024 | 7 |
_a10.1089/08892220050116989 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLook, M P | |
| 245 | 0 | 0 |
_aParallel decrease in neurotoxin quinolinic acid and soluble tumor necrosis factor receptor p75 in serum during highly active antiretroviral therapy of HIV type 1 disease. _h[electronic resource] |
| 260 |
_bAIDS research and human retroviruses _cSep 2000 |
||
| 300 |
_a1215-21 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntigens, CD _xblood |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKynurenine _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aQuinolinic Acid _xblood |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xblood |
| 650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor, Type II |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTryptophan _xblood |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aAltfeld, M | |
| 700 | 1 | _aKreuzer, K A | |
| 700 | 1 | _aRiezler, R | |
| 700 | 1 | _aStabler, S P | |
| 700 | 1 | _aAllen, R H | |
| 700 | 1 | _aSauerbruch, T | |
| 700 | 1 | _aRockstroh, J K | |
| 773 | 0 |
_tAIDS research and human retroviruses _gvol. 16 _gno. 13 _gp. 1215-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/08892220050116989 _zAvailable from publisher's website |
| 999 |
_c10905307 _d10905307 |
||